v3.26.1
Condensed Consolidated Statements of Stockholders' Investment - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (in shares)   118,429     118,429  
Beginning balance $ 1,704,121 $ 1,845,647 $ 1,734,725 $ 1,722,051 $ 1,845,647 $ 1,722,051
Net income 186,786 147,233 152,471 135,302 $ 334,019 287,773
Foreign currency adjustments 399 (431) 28,085 10,435    
Dividends declared (75,485) (74,887) (75,702) (74,418)    
Stock issued for employee benefit plans 8,586 (27,718) 5,458 (33,021)    
Stock-based compensation expense 24,710 28,295 20,882 23,146    
Repurchase of common stock $ (221,427) (214,018) (81,532) (48,770)    
Ending balance (in shares) 117,113       117,113  
Ending balance $ 1,627,690 $ 1,704,121 $ 1,784,387 $ 1,734,725 $ 1,627,690 $ 1,784,387
Common Stock            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (in shares) 118,157 118,429 118,958 118,664 118,429 118,664
Beginning balance $ 11,816 $ 11,843 $ 11,896 $ 11,866 $ 11,843 $ 11,866
Stock issued for employee benefit plans (in shares) 222 959 229 779    
Stock issued for employee benefit plans $ 22 $ 96 $ 23 $ 78    
Repurchase of common stock (in shares) (1,266) (1,231) (870) (485)    
Repurchase of common stock $ (127) $ (123) $ (87) $ (48)    
Ending balance (in shares) 117,113 118,157 118,317 118,958 117,113 118,317
Ending balance $ 11,711 $ 11,816 $ 11,832 $ 11,896 $ 11,711 $ 11,832
Additional Paid-in Capital            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance 692,567 734,261 715,021 775,054 734,261 775,054
Stock issued for employee benefit plans (6,375) (69,989) (11,827) (83,179)    
Stock-based compensation expense 24,710 28,295 20,882 23,146    
Ending balance 710,902 692,567 724,076 715,021 710,902 724,076
Retained Earnings            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance 6,143,464 6,071,118 5,847,221 5,786,337 6,071,118 5,786,337
Net income 186,786 147,233 152,471 135,302    
Dividends declared (75,485) (74,887) (75,702) (74,418)    
Ending balance 6,254,765 6,143,464 5,923,990 5,847,221 6,254,765 5,923,990
Accumulated Other Comprehensive Loss            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (78,105) (77,674) (99,967) (110,402) (77,674) (110,402)
Foreign currency adjustments 399 (431) 28,085 10,435    
Ending balance (77,706) (78,105) (71,882) (99,967) (77,706) (71,882)
Treasury Stock            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (5,065,621) (4,893,901) (4,739,446) (4,740,804) (4,893,901) (4,740,804)
Stock issued for employee benefit plans 14,939 42,175 17,262 50,080    
Repurchase of common stock (221,300) (213,895) (81,445) (48,722)    
Ending balance $ (5,271,982) $ (5,065,621) $ (4,803,629) $ (4,739,446) $ (5,271,982) $ (4,803,629)